Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Thyroid : Official Journal of the American Thyroid Association|April 9, 2026
Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort StudyNatan Lishinsky-Fischer, Rena Pollack, Zvi Gur
Plastic and Reconstructive Surgery|April 7, 2026
Beyond Weight Loss: Association Between Glucagon-like peptide-1 Receptor Agonist Therapy and Incidence of Facial and Oculoplastic ProceduresNatan Lishinsky-Fischer, Shira Amsalem, Tehila Shlomov, et al.
Retina (Philadelphia, Pa.)|June 17, 2026
PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort AnalysisNatan Lishinsky-Fischer, Jaime Levy
The Ocular Surface|February 28, 2026
Effectiveness of Adult Zoster Vaccination in Preventing a First Episode of Zoster Keratitis: A Large-Scale Database StudyYossi Eshel, Natan Lishinsky-Fischer, Itay Nitzan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|January 31, 2026
Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetesTehila Shlomov, Itay Nitzan, Rena Pollack, et al.
Retina (Philadelphia, Pa.)|May 19, 2025
The effects of immunosuppressive therapy for immune-mediated inflammatory disease on the risk of age-related macular degenerationNatan Lishinsky-Fischer, Itay Chowers, Jaime Levy
Eye (London, England)|November 4, 2025
Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort studyElad Eilon, Natan Lishinsky-Fischer, Jaime Levy
Ophthalmology Science|February 3, 2025
Patients with Age-related Macular Degeneration Have Increased Susceptibility to Valvular Heart DiseaseNatan Lishinsky-Fischer, Itay Chowers, Yahel Shwartz, et al.
Eye (London, England)|February 5, 2026
Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world studyShoham Kubovsky, Natan Lishinsky-Fischer, Itay Chowers, et al.
American Journal of Ophthalmology|January 9, 2026
Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Propensity-Matched Cohort StudyNatan Lishinsky-Fischer, Sima Gharra, Itay Nitzan, et al.
Pageof 7